FdaApplication
NDA 216338
Identifiers
- fda_app_no: NDA216338
Properties
| Property | Value |
|---|---|
| applicant_name | TEVA PHARMACEUTICALS INC |
| application_type | NDA |
| approval_date | 2023-05-11 |
Products (1)
| Product | Active ingredient | Strength | Dosage form |
|---|---|---|---|
| PACLITAXEL | PACLITAXEL | 100MG/VIAL | POWDER;INTRAVENOUS |
1 product